Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the agreement, Kolinpharma will use its existing sales network and relationships with relevant clinical communities to market Iron Hydroxide Adipate Tartrate (IHAT), an oral iron supplementation product for iron deficiency, under its brand KIPFeR.
Lead Product(s): Iron Hydroxide Adipate Tartrate
Therapeutic Area: Hematology Product Name: KIPFeR
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Nemysis
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 10, 2024